Fine Mapping of a Region of Chromosome 11q23.3 Reveals Independent Locus Associated with Risk of Glioma

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Chen, Hongyan ^a   Sun, Bing ^b   Zhao, Yingjie ^a   Song, Xiao ^a   Fan, Weiwei ^a   Zhou, Keke ^b   Zhou, Liangfu ^b   Mao, Ying ^b   Lu, Daru ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN;

ACRN1 GENE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CHROMOSOME 11Q; CHROMOSOME MAP; CONTROLLED STUDY; FEMALE; GENE; GENE LOCUS; GENETIC MODEL; GENETIC VARIABILITY; GENOME; GENOTYPE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHDLB1 GENE; PLECKSTRIN HOMOLOGY LIKE DOMAIN FAMILY B MEMBER 1 GENE; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; COATOMER PROTEIN; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HAPLOTYPES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84871813019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052864     Document Type: Article

References (35)

1. Xue QC, Pu PY, Yang YS, Shen CH (1990) A survey of 790 cases of astrocytoma. Clin Neurol Neurosurg 92, 27-33.
2. Ohgaki H, Kleihues P, (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 9: 93-108.
3. National Bureau of Statistics of China. (2009) China's Health Statistics Yearbook 2009 [in Chinese]. Peking, China: Peking Union Medical College Press; 254. Available: http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2009/t-9.htm. Accessed 2010 May 24.
4. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, et al. (2010) Exciting new advances in neuron-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
5. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
6. Schoemaker MJ, Robertson L, Wigertz A, Jones ME, Hosking FJ, et al. (2010) Interaction between 5 genetic variants and allergy in glioma risk. Am J Epidemiol 171: 1165-1173.
7. Chen H, Chen Y, Zhao Y, Fan W, Zhou K, et al. (2011) Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Am J Epidemiol 173: 915-922.
8. Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, et al. (2011) Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer genetics 204: 13-8.
9. Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, et al. (1999) Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18: 4948-4957.
10. Liu Y, Zhou K, Zhang H, Shugart YY, Chen L, Xu Z, et al. (2008) Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 29: 381-389.
11. Liu Y, Zhang H, Zhou K, Chen L, Xu Z, et al. (2007) Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis 28: 1906-1913.
12. Nyholt DR, (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769.
13. Gao X, Starmer J, Martin ER, (2008) A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 32: 361-369.
14. Katoh M, Katoh M, (2003) Identification and characterization of human LL5A gene and mouse Ll5a gene in silico. Int J Oncol 23: 1477-1483.
15. Paranavitane V, Coadwell WJ, Eguinoa A, Hawkins PT, Stephens L, (2003) LL5beta is a phosphatidylinositol (3,4,5)-trisphosphate sensor that can bind the cytoskeletal adaptor, gamma-filamin. J Biol Chem 278: 1328-1335.
16. Paranavitane V, Stephens LR, Hawkins PT, (2007) Structural determinants of LL5beta subcellular localisation and association with filamin C. Cell Signal. 19: 817-824.
17. Lansbergen G, Grigoriev I, Mimori-Kiyosue Y, Ohtsuka T, Higa S, et al. (2006) CLASPs attach microtubule plus ends to the cell cortex through a complex with LL5beta. Dev Cell 11: 21-32.
18. Zhou QL, Jiang ZY, Mabardy AS, Del Campo CM, Lambright DG, et al. (2010) A novel pleckstrin homology domain-containing protein enhances insulin-stimulated Akt phosphorylation and GLUT4 translocation in adipocytes. J Biol Chem 285: 27581-27589.
19. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41: 905-908.
20. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer cell 9: 157-73.
21. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, et al. (2009) IDH1 and IDH2 mutations in gliomas. The New England journal of medicine 360: 765-73.
22. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer cell 17: 510-22.
23. Lee MC, Miller EA, Goldberg J, Orci L, Schekman R, (2004) Bi-directional protein transport between the ER and Golgi. Annu Rev Cell Dev Biol 20: 87-123.
24. Kirchhausen T (2000) Three ways to make a vesicle. Nat Rev Mol Cell Biol 1, 187-198.
25. Bonifacino JS, Glick BS, (2004) The mechanisms of vesicle budding and fusion. Cell 116: 153-166.
26. McMahon HT, Mills IG, (2004) COP and clathrin-coated vesicle budding: different pathways, common approaches. Curr Opin Cell Biol 16: 379-391.
27. Xu X, Kedlaya R, Higuchi H, Ikeda S, Justice MJ, Setaluri V, (2010) Mutation in archain 1, a subunit of COPI coatomer complex, causes diluted coat color and Purkinje cell degeneration. PLoS Genet 6: e1000956.
28. Garcia-Closas M, Malats N, Real FX, Yeager M, Welch R, et al. (2007) Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 3: e29.
29. Churchill AJ, Carter JG, Lovell HC, Ramsden C, Turner SJ, et al. (2006) VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 15: 2955-2961.
30. Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, et al. (2007) Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes 56: 2161-2168.
31. Zhou K, Liu Y, Zhang H, Liu H, Fan W, Zhong Y, et al. (2009) XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study. Int J Cancer 124: 2948-2953.
32. O'Donnell MJ, Little DP, Braun A (1997) MassArray as an enabling technology for the industrial-scale analysis of DNA. Genetic Engineering News 17, 39.
33. Akaike H, (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19: 716-23.
34. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
35. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA, (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70: 425-434.